Fidelity Investments’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,974,455
| Closed | -$168M | – | 4472 |
|
|
2020
Q3 | $168M | Sell |
1,974,455
-9,616,016
| -83% | -$486M | 0.02% | 697 |
|
|
2020
Q2 | $411M | Buy |
11,590,471
+7,360,258
| +174% | +$215M | 0.05% | 369 |
|
|
2020
Q1 | $57M | Sell |
4,230,213
-385,366
| -8% | -$6.48M | 0.01% | 988 |
|
|
2019
Q4 | $97.7M | Sell |
4,615,579
-2,398,442
| -34% | -$42.3M | 0.01% | 919 |
|
|
2019
Q3 | $93M | Sell |
7,014,021
-5,662,109
| -45% | -$83.2M | 0.01% | 924 |
|
|
2019
Q2 | $176M | Sell |
12,676,130
-10,191,724
| -45% | -$153M | 0.02% | 685 |
|
|
2019
Q1 | $439M | Buy |
22,867,854
+14,632,374
| +178% | +$236M | 0.05% | 347 |
|
|
2018
Q4 | $118M | Buy |
8,235,480
+2,677,246
| +48% | +$53.1M | 0.02% | 775 |
|
|
2018
Q3 | $116M | Sell |
5,558,234
-2,935,948
| -35% | -$69.5M | 0.01% | 885 |
|
|
2018
Q2 | $201M | Buy |
8,494,182
+699,658
| +9% | +$14.1M | 0.02% | 661 |
|
|
2018
Q1 | $114M | Buy |
7,794,524
+3,014,073
| +63% | +$49.2M | 0.01% | 926 |
|
|
2017
Q4 | $77.3M | Sell |
4,780,451
-716,400
| -13% | -$8.46M | 0.01% | 1106 |
|
|
2017
Q3 | $76.8M | Hold |
5,496,851
| – | – | 0.01% | 1094 |
|
|
2017
Q2 | $48.5M | Buy |
5,496,851
+3,972,388
| +261% | +$27.9M | 0.01% | 1294 |
|
|
2017
Q1 | $9.86M | Buy |
1,524,463
+391,815
| +35% | +$1.98M | ﹤0.01% | 1973 |
|
|
2016
Q4 | $4.16M | Hold |
1,132,648
| – | – | ﹤0.01% | 2222 |
|
|
2016
Q3 | $3.68M | Hold |
1,132,648
| – | – | ﹤0.01% | 2258 |
|
|
2016
Q2 | $2.63M | Sell |
1,132,648
-10,033,400
| -90% | -$33.5M | ﹤0.01% | 2328 |
|
|
2016
Q1 | $27.9M | Sell |
11,166,048
-1,957,150
| -15% | -$4.4M | ﹤0.01% | 1506 |
|
|
2015
Q4 | $40.3M | Sell |
13,123,198
-1,070,688
| -8% | -$2.99M | 0.01% | 1344 |
|
|
2015
Q3 | $24.4M | Buy |
14,193,886
+174,217
| +1% | +$445K | ﹤0.01% | 1579 |
|
|
2015
Q2 | $56.9M | Buy |
14,019,669
+188,722
| +1% | +$772K | 0.01% | 1286 |
|
|
2015
Q1 | $53M | Sell |
13,830,947
-100,000
| -0.7% | -$435K | 0.01% | 1304 |
|
|
2014
Q4 | $66.9M | Buy |
13,930,947
+124,095
| +0.9% | +$491K | 0.01% | 1198 |
|
|
2014
Q3 | $51.4M | Buy |
13,806,852
+69,700
| +0.5% | +$236K | 0.01% | 1296 |
|
|
2014
Q2 | $50.1M | Buy |
13,737,152
+1,242,483
| +10% | +$4.56M | 0.01% | 1335 |
|
|
2014
Q1 | $52.6M | Buy |
12,494,669
+24,527
| +0.2% | +$122K | 0.01% | 1297 |
|
|
2013
Q4 | $57.4M | Buy |
12,470,142
+29,799
| +0.2% | +$133K | 0.01% | 1248 |
|
|
2013
Q3 | $77M | Buy |
12,440,343
+1,000,372
| +9% | +$5.76M | 0.01% | 1074 |
|
|
2013
Q2 | $62.2M | Buy |
+11,439,971
| New | +$37.6M | 0.01% | 1132 |
|
Fidelity Investments's IMMU Position: Q4 2020 in Review
Fidelity Investments sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,974,455 shares — an estimated $168M sold.
Fidelity Investments first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $439M in Q1 2019. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Fidelity Investments reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Fidelity Investments sold 1,974,455 Immunomedics Inc shares in Q4 2020, an estimated $168M.
- Fidelity Investments first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- Fidelity Investments's Immunomedics Inc position peaked at $439M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Fidelity Investments's 13F filing for Q4 2020, filed 8 Feb 2021.